Delays in breast cancer diagnosis and treatment highlight the need for improved human capital investment in health care ...

Tolion Health AI, a digital health company developing artificial intelligence solutions for personalized, predictive, and ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

The appointment expands the current Board of Directors' role to oversee Psilera's clinical development strategy for its next-generation neuroplastogens.

Enrique Velazquez Villarreal, MD, PhD, MPH, MS, reveals how AI is being used to identify early-onset CRC and enhance ...

Jennifer E. Thorne, MD, PhD, is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine in Baltimore, Maryland.

Scientists have carried out research in mice that suggests it could be possible to reverse the disease although trials with ...

UCSF researchers have discovered a way to identify deadly lung infections with improved accuracy by pairing AI with a unique ...

Both the new weight loss drugs and bariatric (weight loss) surgery improve body composition in patients with obesity by ...

The new CDC recommendation takes a much narrower view of the meningococcal disease threat. Because of "the low incidence ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class Non-VEGF-Targeted Therapeutics for Wet AMD ...